News

September 2026

When Every Second Matters: Rapid MRSA Detection in Severe Infections

Yesterday was World Sepsis Day. Today, the message remains: when an infection becomes life-threatening, every decision matters.

One of the key challenges in managing severe infections is rapidly identifying the causative pathogen. Methicillin-resistant Staphylococcus aureus (MRSA) remains a major global healthcare challenge, capable of causing serious infections and complicating treatment. In healthcare settings, timely and reliable detection of MRSA can support appropriate treatment and infection prevention decisions, helping healthcare professionals respond effectively to potentially life-threatening infections.

Distinguishing between MRSA, MSSA, and VRSA is essential for guiding appropriate treatment and infection control measures.

🔬  Friz Biochem presents its IVDR-certified MRSA direct PCR assay (Ref. No.: (FBC131), enabling the detection and differentiation of the following targets without DNA extraction or purification, directly from nasal/throat swabs, skin/wound swabs, or culture samples:

• Methicillin-resistant Staphylococcus aureus (MRSA) – orfX, mecA/mecC genes
• Vancomycin-resistant Staphylococcus aureus(VRSA) – vanA gene
• Methicillin-susceptible Staphylococcus aureus (MSSA) –spa gene

From individual testing to high-throughput workflows with different configuration options, our MRSA direct PCR solutions offer the flexibility your laboratory needs.

Image credit: CDC Public Health Image Library (PHIL), PHIL ID 23234

July 2026

Summer Party 2026

Summer is the perfect time to reflect on what we’ve accomplished and enjoy some well-deserved time together. 

Our summer party was a wonderful chance to celebrate our achievements as a team, spend quality time together, and create new memories over great food, conversations, and plenty of laughs.  

Strong teams aren’t built only through hard work, they also grow through shared experiences and moments like these. A big thank you to Friz Biochem team and to Opto GmbH, mbiomics GmbH, Baseclick GmbH and invicon diagnostic concepts GmbH for organizing such a wonderful event! 

Now it’s time to recharge, enjoy the summer, and continue with fresh energy for the exciting challenges ahead. 

July 2026

10 new IVDR-compliant
qPCR assays

We’re proud to announce the certification of 10 new products under Regulation (EU) 2017/746 (IVDR), expanding our portfolio of fast, reliable, and compliant molecular diagnostic solutions for clinical laboratories.

Discover our complete IVDR-certified product portfolio and download the overview here: FRIZ Biochem – Lab direct qPCR

Our IVDR-certified portfolio now covers a broad range of applications, including:

🫁 Respiratory diagnostics
• res1plex–res6plex direct PCR/RT-PCR assays for bacterial and viral
respiratory pathogens
• COVID-19 direct RT-PCR for SARS-CoV-2 detection

🧪 Gastrointestinal diagnostics
• GastroBac, GastroVir1, GastroVir2, and Helicobacter direct PCR assays covering key bacterial, viral, and resistance targets

🏥 Hospital-acquired infections
• MRSA direct PCR for detection of methicillin-resistant and/or
vancomycin-resistant Staphylococcus aureus

Together with our previously certified res4plex direct RT-PCR and GastroBac direct PCR assays, these additions further strengthen our commitment to delivering innovative, IVDR-compliant molecular diagnostics.

March 2026

GastroBac direct PCR – Launch

🚀 Milestone achieved: IVDR certification for GastroBac direct PCR

GastroBac direct  PCR is designed to provide fast, reliable, and accurate detection of major gastro-intestinal bacterial pathogens, including:

• Campylobacter spp.
• Salmonella spp.
• Shigella spp. / enteroinvasive E. coli (EIEC)
• Yersinia enterocolitica
• Yersinia pseudotuberculosis

A big thank you to our team and partners, this achievement reflects the expertise, dedication, and collaboration behind everything we do. We look forward to continuing to support healthcare professionals with reliable diagnostic solutions.

Dezember 2025

🎄Merry Christmas & Thank You!

As the year comes to an end, we would like to take a moment to say thank you:

Thank you to our incredible team for their dedication, passion, and teamwork.

Thank you to our partners and customers for your trust and successful collaboration throughout the year.

Wishing everyone a joyful holiday season, relaxing moments with loved ones, and a great start to the new year. ✨

October 2025

Diagnostics-4-Future

Two of our colleagues joined the Diagnostics-4-Future Conference 2025 in Konstanz and came back energized with new contacts, ideas, and inspiration.

It was a great experience to explore the latest developments in AI-based diagnostics, innovative approaches to combating antibiotic resistance, the challenges of overdiagnosis, and sustainable, green diagnostics.

The event offered an exciting look into current trends and innovations across diagnostics, life sciences, and MedTech.

Many thanks to BioLAGO e.V. – the health network for organizing such a fantastic event – we’re already looking forward to next year!

April 2025

FRIZ is now EU-IVDR certified

We are proud to announce that we have successfully achieved certification under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR) (EU) 2017/746.

This certification marks a significant milestone in our commitment to delivering safe, high-quality, and compliant diagnostic solutions to our customers across Europe. It reflects the hard work, dedication, and collaboration of our entire team, as well as our continued investment in quality management and regulatory excellence.

Explore our products.

November 2024

MEDICA 2024

We’re excited to share the success of our recent visit to MEDICA in Düsseldorf! It was a great opportunity to showcase our latest products and engage with customers, partners, and industry experts.

We had insightful conversations, received positive feedback, and presented our latest innovations. We’re thrilled by the interest shown and grateful to all who visited our booth.

Thank you to everyone who supported us – we look forward to future collaborations!